KOL Perspectives: Rituximab Use in Lupus

Market: Pharmaceuticals and Healthcare

Global, 37 pages report, published by GlobalData

Report ThumbnailJuly-2018
KOL Perspectives: Rituximab Use in Lupus

Summary

This KOL Insight briefing focuses on KOLs views of Rituximab Use in Lupus.

Questions topics -
- Current & future use of RTX in lupus
- Views on RTX’s Phase II/III EXPLORER trial re-analysis
- Opinion on data demonstrating that RTX is effective for the management of refractory SLE
- Views on data from the Phase II SYNBIoSe study assessing RTX + BEL combination therapy
- Lupus patients most suitable for RTX + BEL combination therapy
- Use of RTX

Read More
  • Table of Contents
  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix
Read More

Please select a license type

Share

Related Products

GlobalDataKOL Perspectives: Rituximab Use in LupusProduct ThumbnailKOL Perspectives: Rituximab Use in Lupus, Industry ReportProduct #: 1194014
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved